Clinical Trial Update: To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial assessing the safety and initial efficacy of STSA-1002 Injection in patients with acute respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• STSA-1002 Injection (STSA-1002)

Snippet

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd | Conditions: Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: COMPLETED